| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |